Loading...
The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination
Despite extensive preclinical evidence that peroxisome proliferator-activated receptor (PPAR)γ activation protects against tumourigenesis, results from a few clinical trials using PPARγ ligands as monotherapy show modest success. In spite of this, several groups reported exciting results with therap...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi Publishing Corporation
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3395155/ https://ncbi.nlm.nih.gov/pubmed/22966225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/946943 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|